New Tool: ProSource
Checkout our packaging and processing solutions finder.
Start Your Search

Pfizer Recalls 500,000+ Vials of Protonix

Pfizer issues a voluntary class III recall of its gastrointestinal medication due to potency issues.

Protonix
Protonix

A recent FiercePharma article noted the recall of 582,165 vials of Pfizer’s Protonix, a gastrointestinal medication that’s basically a magnet for litigation. The class III recall was initiated back in November when it became known the proton-pump inhibitor may be subpotent, but it took the FDA took four months to classify the recall. In December, a generic version of the drug, made by India’s Aurobindo, was recalled.

In 2007, Teva and Sun Pharma launched at-risk generics of Protonix before others existed on the market, but a jury deemed the Protonix patent valid in 2010. In 2013, Sun payed $550 million of a $2.15 billion infringement settlement to then owners Pfizer and Takeda. And just last year Pfizer paid out $786 million in a settlement with the Department of Justice, which claimed Wyeth (acquired by Pfizer in 2009) overcharged Medicaid for the drug.

Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Unlock Learning Here
Discover Our Content Hub
Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Take Quiz
Test Your Supply Chain Smarts